SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-169790
Filing Date
2017-05-15
Accepted
2017-05-15 08:16:51
Documents
45
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d289810d10q.htm 10-Q 242760
2 EX-31.1 d289810dex311.htm EX-31.1 9557
3 EX-31.2 d289810dex312.htm EX-31.2 9654
4 EX-32.1 d289810dex321.htm EX-32.1 4593
5 EX-32.2 d289810dex322.htm EX-32.2 4585
  Complete submission text file 0001193125-17-169790.txt   1840884

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT galt-20170331.xml EX-101.INS 210496
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20170331.xsd EX-101.SCH 27828
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20170331_cal.xml EX-101.CAL 28232
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20170331_def.xml EX-101.DEF 166535
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20170331_lab.xml EX-101.LAB 230796
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20170331_pre.xml EX-101.PRE 197122
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 17841221
SIC: 2834 Pharmaceutical Preparations